Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Non-Current Assets: 2011-2018

Historic Non-Current Assets for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $31.8 million.

  • EyePoint Pharmaceuticals' Non-Current Assets rose 3.08% to $33.5 million in Q1 2019 from the same period last year, while for Mar 2019 it was $33.5 million, marking a year-over-year increase of 3.08%. This contributed to the annual value of $31.8 million for FY2018, which is 3289.65% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Non-Current Assets stood at $31.8 million for FY2018, which was up 3,289.65% from $937,000 recorded in FY2017.
  • In the past 5 years, EyePoint Pharmaceuticals' Non-Current Assets ranged from a high of $31.8 million in FY2018 and a low of $937,000 during FY2017.
  • For the 3-year period, EyePoint Pharmaceuticals' Non-Current Assets averaged around $11.5 million, with its median value being $1.7 million (2016).
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Non-Current Assets plummeted by 43.42% in 2017, and later spiked by 3,289.65% in 2018.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Non-Current Assets stood at $3.3 million in 2014, then dropped by 24.03% to $2.5 million in 2015, then tumbled by 34.52% to $1.7 million in 2016, then tumbled by 43.42% to $937,000 in 2017, then soared by 3,289.65% to $31.8 million in 2018.